(RCUS) Arcus Biosciences - Performance -39.2% in 12m
RCUS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-75.70%
#115 in Peer-Group
Rel. Strength
13.53%
#6662 in Stock-Universe
Total Return 12m
-39.15%
#112 in Peer-Group
Total Return 5y
-61.86%
#72 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 18.44 USD |
| 52 Week Low | 6.87 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 76.83 |
| Buy/Sell Signal +-5 | 0.40 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: RCUS (-39.2%) vs XBI (-11.7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.74% | 53.2% | 70.2% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
3.64% | -10.3% | 158% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.83% | -8.28% | 33.6% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
7.39% | -7.29% | 0.13% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-1% | 26.9% | -7.57% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
4.06% | 31.3% | -17.2% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.56% | 41.9% | -8.93% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
- | 27% | 13.6% | 28.8 | 15.2 | 0.63 | -62.1% | -19.3% |
Performance Comparison: RCUS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RCUS
| Total Return (including Dividends) | RCUS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 8.28% | 7.34% | 5.42% |
| 3 Months | 19.54% | 16.06% | 19.66% |
| 12 Months | -39.15% | -11.67% | 14.17% |
| 5 Years | -61.86% | -26.49% | 107.98% |
| Trend Stabilty (consistency of price movement) | RCUS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 47.2% | 88.2% | 91.9% |
| 3 Months | 43.1% | 79.7% | 97.6% |
| 12 Months | -82.1% | -86.7% | 47.9% |
| 5 Years | -82.2% | -51.5% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th51.00 | 0.87% | 2.71% |
| 3 Month | %th53.50 | 3.00% | -0.10% |
| 12 Month | %th45.00 | -31.10% | -46.70% |
| 5 Years | %th65.00 | -48.12% | -81.66% |
FAQs
Does Arcus Biosciences (RCUS) outperform the market?
No,
over the last 12 months RCUS made -39.15%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.67%.
Over the last 3 months RCUS made 19.54%, while XBI made 16.06%.
Performance Comparison RCUS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
RCUS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.6% | 2.9% | -38.6% | -53% |
| US NASDAQ 100 | QQQ | -2.4% | 2% | -40.8% | -56% |
| German DAX 40 | DAX | -0.9% | 4.3% | -48.9% | -71% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -2.1% | 2.2% | -42.4% | -58% |
| Hongkong Hang Seng | HSI | -2.9% | 3.8% | -59.1% | -74% |
| India NIFTY 50 | INDA | -0.8% | 6.1% | -40.3% | -36% |
| Brasil Bovespa | EWZ | -1.2% | 9.8% | -52.6% | -41% |
RCUS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.2% | 4.9% | -43% | -65% |
| Consumer Discretionary | XLY | -0.7% | 3.4% | -29.4% | -55% |
| Consumer Staples | XLP | -1.3% | 6.9% | -39.2% | -45% |
| Energy | XLE | 1.1% | 9.7% | -26.6% | -35% |
| Financial | XLF | -0.9% | 3.4% | -38.1% | -61% |
| Health Care | XLV | 1.4% | 8.4% | -28.4% | -29% |
| Industrial | XLI | -2% | 1.5% | -43.7% | -61% |
| Materials | XLB | 1.2% | 4.6% | -35.8% | -39% |
| Real Estate | XLRE | -1.5% | 7.5% | -36% | -45% |
| Technology | XLK | -2.9% | -0.1% | -44.8% | -56% |
| Utilities | XLU | -1% | 5.1% | -38.8% | -60% |
| Aerospace & Defense | XAR | -7.6% | -4.6% | -62.2% | -92% |
| Biotech | XBI | -1% | 0.9% | -33% | -27% |
| Homebuilder | XHB | 2.2% | -1.8% | -25.8% | -31% |
| Retail | XRT | 0.5% | 3.8% | -34.7% | -42% |
RCUS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -2.3% | 15.7% | -25.2% | -34% |
| Natural Gas | UNG | -7.7% | 19% | -18.5% | -53% |
| Gold | GLD | -1.7% | 9.7% | -56.3% | -75% |
| Silver | SLV | -3.9% | 5.6% | -58.4% | -64% |
| Copper | CPER | 0.6% | -5.7% | -58.2% | -64% |
RCUS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.9% | 9.5% | -32.6% | -33% |
| iShares High Yield Corp. Bond | HYG | -1.3% | 6.9% | -36.7% | -48% |